These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36811256)

  • 1. The use of the second thoracic vertebral landmark for skeletal muscle assessment and computed tomography-defined sarcopenia evaluation in patients with head and neck cancer.
    Vangelov B; Bauer J; Moses D; Smee R
    Head Neck; 2023 Apr; 45(4):1006-1016. PubMed ID: 36811256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prediction model for skeletal muscle evaluation and computed tomography-defined sarcopenia diagnosis in a predominantly overweight cohort of patients with head and neck cancer.
    Vangelov B; Bauer J; Moses D; Smee R
    Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):321-328. PubMed ID: 35835910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thoracic skeletal muscle index is effective for CT-defined sarcopenia evaluation in patients with head and neck cancer.
    Vangelov B; Smee R; Moses D; Bauer J
    Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5583-5594. PubMed ID: 37573279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of skeletal muscle evaluation at the third cervical vertebral level for computed tomography-defined sarcopenia assessment in patients with head and neck cancer.
    Vangelov B; Bauer J; Moses D; Smee R
    Head Neck; 2022 May; 44(5):1047-1056. PubMed ID: 35138008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of using head and neck CT imaging to assess skeletal muscle mass in head and neck cancer patients.
    Swartz JE; Pothen AJ; Wegner I; Smid EJ; Swart KM; de Bree R; Leenen LP; Grolman W
    Oral Oncol; 2016 Nov; 62():28-33. PubMed ID: 27865369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of head and neck computed tomography for skeletal muscle mass estimation in patients with head and neck cancer.
    Jung AR; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2019 Aug; 95():95-99. PubMed ID: 31345401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The validation of low-dose CT scans from the [
    Zwart AT; Cavalheiro VJ; Lamers MJ; Dierckx RAJO; de Bock GH; Halmos GB; van der Hoorn A
    Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1735-1742. PubMed ID: 36781423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of alternate vertebral levels to L3 in computed tomography scans for skeletal muscle mass evaluation and sarcopenia assessment in patients with cancer: a systematic review.
    Vangelov B; Bauer J; Kotevski D; Smee RI
    Br J Nutr; 2022 Mar; 127(5):722-735. PubMed ID: 33910664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of CT derived body composition at the thoracic T4 and T12 with lumbar L3 vertebral levels and their utility in patients with rectal cancer.
    Arayne AA; Gartrell R; Qiao J; Baird PN; Yeung JM
    BMC Cancer; 2023 Jan; 23(1):56. PubMed ID: 36647027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Masticatory muscle index for indicating skeletal muscle mass in patients with head and neck cancer.
    Chang SW; Tsai YH; Hsu CM; Huang EI; Chang GH; Tsai MS; Tsai YT
    PLoS One; 2021; 16(5):e0251455. PubMed ID: 33970954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skeletal muscle mass and sarcopenia can be determined with 1.5-T and 3-T neck MRI scans, in the event that no neck CT scan is performed.
    Zwart AT; Becker JN; Lamers MJ; Dierckx RAJO; de Bock GH; Halmos GB; van der Hoorn A
    Eur Radiol; 2021 Jun; 31(6):4053-4062. PubMed ID: 33219847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Skeletal Muscle Changes at Three Vertebral Levels Following Radiotherapy in Patients With Oropharyngeal Carcinoma.
    Vangelov B; Bauer J; Moses D; Smee R
    Nutr Cancer; 2023; 75(2):572-581. PubMed ID: 36308327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal muscle mass at C3 may not be a strong predictor for skeletal muscle mass at L3 in sarcopenic patients with head and neck cancer.
    Yoon JK; Jang JY; An YS; Lee SJ
    PLoS One; 2021; 16(7):e0254844. PubMed ID: 34280248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing skeletal muscle mass based on the cross-sectional area of muscles at the 12th thoracic vertebra level on computed tomography in patients with oral squamous cell carcinoma.
    Matsuyama R; Maeda K; Yamanaka Y; Ishida Y; Kato R; Nonogaki T; Shimizu A; Ueshima J; Kazaoka Y; Hayashi T; Ito K; Furuhashi A; Ono T; Mori N
    Oral Oncol; 2021 Feb; 113():105126. PubMed ID: 33388617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CT-measured skeletal muscle mass used to assess frailty in patients with head and neck cancer.
    Zwart AT; van der Hoorn A; van Ooijen PMA; Steenbakkers RJHM; de Bock GH; Halmos GB
    J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1060-1069. PubMed ID: 31134765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of using chest computed tomography (CT) imaging at the first lumbar vertebra (L1) level to assess skeletal muscle mass: a retrospective study.
    Liu S; Han X; Li J; Xie X; Yang Y; Jiang W; Liu L; Liu Z
    PeerJ; 2023; 11():e16652. PubMed ID: 38099314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the prognosis of oral squamous cell carcinoma patients via L3 skeletal muscle index.
    Lu X; Tian Y; Huang J; Li F; Shao T; Huang G; Lv X
    Oral Dis; 2023 Apr; 29(3):923-932. PubMed ID: 34773352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of skeletal muscle mass assessment at the level of the third cervical vertebra in patients with head and neck cancer.
    Bril SI; Chargi N; Wendrich AW; Wegner I; Bol GH; Smid EJ; de Jong PA; Devriese LA; de Bree R
    Oral Oncol; 2021 Dec; 123():105617. PubMed ID: 34749251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Software Selection and ImageJ Tutorial Corrigendum on Skeletal Muscle Measures at the Third Lumbar Vertebra on Computed Tomography Scans in Clinical Populations.
    Teigen LM; Kuchnia AJ; Nagel E; Deuth C; Vock DM; Mulasi U; Earthman CP
    JPEN J Parenter Enteral Nutr; 2018 Jul; 42(5):933-941. PubMed ID: 30001463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Skeletal Muscle Depletion on Head and Neck Squamous Cell Carcinoma.
    Nishikawa D; Hanai N; Suzuki H; Koide Y; Beppu S; Hasegawa Y
    ORL J Otorhinolaryngol Relat Spec; 2018; 80(1):1-9. PubMed ID: 29393251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.